The argument with no bid, is that the product appears to work well with a number of different drugs and is very safe. This is worth money to a number of drug companies, we are selling to one. If we licenced the product after approval I believe the revenue would be worth a far higher valuation.
Very Disappointed, page-33
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)